1. Home
  2. AVNW vs FHTX Comparison

AVNW vs FHTX Comparison

Compare AVNW & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • FHTX
  • Stock Information
  • Founded
  • AVNW 2006
  • FHTX 2015
  • Country
  • AVNW United States
  • FHTX United States
  • Employees
  • AVNW N/A
  • FHTX N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • AVNW Technology
  • FHTX Health Care
  • Exchange
  • AVNW Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • AVNW 274.4M
  • FHTX 278.1M
  • IPO Year
  • AVNW 2007
  • FHTX 2020
  • Fundamental
  • Price
  • AVNW $22.35
  • FHTX $5.77
  • Analyst Decision
  • AVNW Strong Buy
  • FHTX Strong Buy
  • Analyst Count
  • AVNW 5
  • FHTX 6
  • Target Price
  • AVNW $37.60
  • FHTX $11.33
  • AVG Volume (30 Days)
  • AVNW 104.5K
  • FHTX 84.1K
  • Earning Date
  • AVNW 11-04-2025
  • FHTX 11-03-2025
  • Dividend Yield
  • AVNW N/A
  • FHTX N/A
  • EPS Growth
  • AVNW N/A
  • FHTX N/A
  • EPS
  • AVNW N/A
  • FHTX N/A
  • Revenue
  • AVNW $435,926,000.00
  • FHTX $24,173,000.00
  • Revenue This Year
  • AVNW $8.50
  • FHTX $43.75
  • Revenue Next Year
  • AVNW $5.18
  • FHTX $1.27
  • P/E Ratio
  • AVNW N/A
  • FHTX N/A
  • Revenue Growth
  • AVNW 14.58
  • FHTX N/A
  • 52 Week Low
  • AVNW $12.96
  • FHTX $2.95
  • 52 Week High
  • AVNW $26.87
  • FHTX $10.25
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 49.22
  • FHTX 58.68
  • Support Level
  • AVNW $21.60
  • FHTX $5.14
  • Resistance Level
  • AVNW $24.50
  • FHTX $5.46
  • Average True Range (ATR)
  • AVNW 0.90
  • FHTX 0.37
  • MACD
  • AVNW 0.02
  • FHTX 0.05
  • Stochastic Oscillator
  • AVNW 38.57
  • FHTX 99.03

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: